Home | Sitemap | Contact Us     Search Ranbaxy for  
  Quick Links
 
 
   
   
 
    
 
     
 
   
 
 


Home
Investor Relations > Financials > Cash Flow > Ranbaxy Laboratories Limited
 

     Cash Flow


Untitled Document

 
CASH FLOW STATEMENT
FOR THE YEAR ENDED DECEMBER 31, 2006
   
Rs. in Million
   
2006
2005
A. CASH FLOW FROM OPERATING ACTIVITIES
  Net profit before exceptional items
4,429.76
1,901.34
  Adjustments for :
  Depreciation / Amortization
1,067.50
1,013.33
  Assets written off
2.14
29.54
  Deferred employees compensation
26.35
32.68
  Unrealised foreign exchange gain
(270.74)
(221.54)
  Dividend income
(10.25)
(30.91)
  Profit on disposal of investments
(0.01)
(424.50)
  (Profit) / Loss on sale of fixed assets (Net)
(3.54)
29.29
  Interest expense
584.44
264.11
  Interest income
(201.05)
(139.76)
  Amounts written off
18.16
163.27
  Provision / (Reversal) for doubtful debts and advances
44.74
(225.08)
   
1,257.74
490.43
  Operating profit before working capital changes
5,687.50
2,391.77
  Adjustments for :
  Inventories
(639.79)
(278.31)
  Sundry debtors / receivables
(2,283.67)
(110.69)
  Loans and advances
(451.01)
158.95
  Trade / Other payables
122.66
(743.88)
  Other current assets
513.23
(566.61)
   
(2,738.58)
(1,540.54)
  Net cash generated from operating activity
2,948.92
851.23
  Direct taxes paid (Net of refunds)
205.94
221.94
  Net cash from operating activities
3,154.86
1,073.17
B. CASH FLOW FROM INVESTING ACTIVITIES
  Purchase of fixed assets / capital works-in-progress
(2,158.19)
(6,258.89)
  Consideration received for discontinued business
780.10
  Sale proceeds of fixed assets
61.11
91.35
  Investment in Subsidiaries
(202.00)
(878.89)
  Other investments
(18,969.70)
(13.64)
  Sale proceeds of investments
0.01
480.00
  Short term deposit / secured loans
16.35
5.68
  Interest received
204.81
135.73
  Dividend received
10.25
30.91
  Net cash used in investing activities
(21,037.36)
(5,627.65)
C. CASH FLOW FROM FINANCING ACTIVITIES
  Proceeds from issue of capital (including premium)
63.32
135.53
  Increase in bank borrowings
2,153.73
9,101.29
  Proceeds from FCCB
19,553.60
  Increase / (Decrease) in other borrowings
38.56
(5.14)
  Interest paid
(573.73)
(262.12)
  FCCB issue expenses
(227.50)
  Dividend paid
(3,167.27)
(3,164.26)
  Tax on Dividend
(444.20)
(443.80)
  Net cash from financing activities
17,396.51
5,361.50
  INCREASE / (DECREASE) IN CASH AND CASH EQUIVALENTS
(485.99)
807.02
  Cash and cash equivalents at the beginning
1,109.56
302.54
  Cash and cash equivalents at the close
623.57
1,109.56
Notes :
  Cash and cash equivalents include :
  Cash and cheques in hand and remittances in transit
80.48
204.93
  With banks in :
  Current accounts [Net of dividend accounts Rs. 87.06 Mn (Previous year Rs. 55.27 Mn)]
103.09
44.63
  Deposit accounts [Net of pledged Rs. 0.88 Mn (Previous year Rs. 1.05 Mn)]
440.00
860.00
   
623.57
1,109.56
This is the cash flow statement referred to in our report of even date

  On behalf of the Board of Directors
 
For WALKER, CHANDIOK & CO
Chartered Accountants

TEJENDRA KHANNA
Chairman

VINOD CHANDIOK
Partner
Membership No. 10093

DR. BRIAN W. TEMPEST
Chief Mentor &
Executive Vice Chairman

MALVINDER MOHAN SINGH
CEO & Managing Director

 

ATUL SOBTI
Chief Operating Officer &
Whole-time Director

  RAM S. RAMASUNDAR
President & CFO

Place   :  Gurgaon
Dated  :  March 29, 2007


SUSHIL K. PATAWARI

Secretary